טוען...
Mesenchymal stem cells attenuate MRI-identifiable injury, protect white matter and improve long-term functional outcomes after neonatal focal stroke in the rat
Cell therapy has emerged as a potential treatment for many neurodegenerative diseases including stroke and neonatal ischemic brain injury. Delayed intranasal administration of mesenchymal stem cells (MSC) after experimental hypoxia-ischemia and after a transient middle cerebral artery occlusion (tMC...
שמור ב:
| הוצא לאור ב: | J Neurosci Res |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5352529/ https://ncbi.nlm.nih.gov/pubmed/27781299 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jnr.23954 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|